Olfactory dysfunction in COVID-19 pandemic and its long-term outcome
DOI:
https://doi.org/10.18203/issn.2454-5929.ijohns20231414Keywords:
COVID-19, Pandemic, Coronavirus, Smell disturbance, Olfaction, ODAbstract
Background: Olfactory dysfunction (OD) has commonly affected covid infected patients. This study is done to detect, analyse and study the recovery pattern of OD in laboratory confirmed COVID-19 infected patients since there is very less data available on OD recovery rate.
Methods: Study design is a prospective cohort type and patients were followed up over 16 months of duration. Data was collected of COVID-19 positive patients from January 2020 to May 2021 who were hospitalized and seen after discharge in out-patient department of tertiary care Santosh medical college and hospital, Ghaziabad (Delhi NCR). In these patients, university of Pennsylvania smell identification test (UPSIT)-40 was used for assessment of OD.
Results: Total number of patients enrolled in the study were 153 of which 15 were lost to follow-up. None of the patients died. Among the 138 hospitalized patients with RTPCR-confirmed COVID-19 infection [mean (SD) age, 38.91 (13.90) years; 70 males (50.7%); 68 females (49.3%)]. This is a prospective cohort study studied over 16 months. At the time of diagnosis of COVID-19, smell sensation was categorised based on UPSIT test as anosmic in 69.6% of the patients, severely amosmic in 9.4%, moderately anosmic in 12.3%, mildly anosmic in 8.7%. After a follow-up for 16 months, full recovery was observed in 125 patients (90.6%).
Conclusions: Prognosis for recovery of olfaction dysfunction in COVID-19 patients was favourable. Individuals with sudden onset and gradual onset OD had higher rate of recovery over one-month follow-up period. Sudden onset OD had higher rate of recovery than gradual onset.
References
Huang C. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506.
Rodriguez-Morales AJ. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. 2020;34.
Vaira LA. Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases. Head Neck. 2020;42:1252-8.
Giacomelli A. Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin Infect Dis. 2020;71:889-90.
Suzuki M. Identification of viruses in patients with post-viral olfactory dysfunction. Laryngoscope. 2007;117:272-7.
Koyuncu OO, Hogue IB, Enquist LW. Virus infections in the nervous system. Cell Host and Microbe. 2013;13:379-93.
Spinato G. Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection. JAMA. 2020;323:2089-91.
Huang C. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395:497-506.
Doty RL, Shaman P, Kimmelman CP, Dann MS. University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic. Laryngoscope. 1984;94:176-8.
Chen N. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395:507-13.
Gane SB, Kelly C, Hopkins C. Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome? 2020;20:114.
Brämerson A, Johansson L, Ek L, Nordin S, Bende M. Prevalence of Olfactory Dysfunction: The Skövde Population-Based Study. Laryngoscope. 2004;114:733-7.
Lechien JR. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Oto-Rhino-Laryngol. 2020;277:2251-61.
Mao L. Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683-90.
Yan CH, Faraji F, Prajapati DP, Boone CE, DeConde AS. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms. Int Forum Allergy Rhinol. 2020;10:806-13.
Moein ST. Smell dysfunction: a biomarker for COVID-19. Int Forum Allergy Rhinol. 2020;10:944-50.
